About DESTINY-Ovarian01 DESTINY-Ovarian01 is a global, multicenter, randomized, open-label, phase 3 trial evaluating the efficacy and safety of ENHERTU (5.4 mg/kg) in combination with bevacizumab ...
As Destiny 2 gets closer to its tenth anniversary, the shared world action-RPG is currently at something of a crossroads. Following the end of The Final Shape, many players struggled to keep up with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results